These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19863903)

  • 21. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012.
    Alves Beuttemmüller E; Woodward A; Rash A; Dos Santos Ferraz LE; Fernandes Alfieri A; Alfieri AA; Elton D
    Virol J; 2016 Mar; 13():45. PubMed ID: 26993620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies.
    Kirkland PD; Delbridge G
    Aust Vet J; 2011 Jul; 89 Suppl 1():45-6. PubMed ID: 21711288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin I concentrations in ponies challenged with equine influenza virus.
    Durando MM; Birks EK; Hussey SB; Lunn DP
    J Vet Intern Med; 2011; 25(2):339-44. PubMed ID: 21314723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.
    Chambers TM; Quinlivan M; Sturgill T; Cullinane A; Horohov DW; Zamarin D; Arkins S; García-Sastre A; Palese P
    Equine Vet J; 2009 Jan; 41(1):87-92. PubMed ID: 19301588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination program in the response to the 2007 equine influenza outbreak in Australia.
    Perkins NR; Webster WR; Wright T; Denney I; Links I
    Aust Vet J; 2011 Jul; 89 Suppl 1():126-34. PubMed ID: 21711310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
    Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
    Adams AA; Sturgill TL; Breathnach CC; Chambers TM; Siger L; Minke JM; Horohov DW
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):128-40. PubMed ID: 21035197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive results in a real-time PCR for type A influenza associated with the use of an inactivated vaccine.
    Diallo I; Read AJ; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():145-6. PubMed ID: 21711315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equine influenza: a review of an unpredictable virus.
    Daly JM; MacRae S; Newton JR; Wattrang E; Elton DM
    Vet J; 2011 Jul; 189(1):7-14. PubMed ID: 20685140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
    Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
    Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine.
    Kannegieter NJ; Frogley A; Crispe E; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():139-42. PubMed ID: 21711313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred.
    van Maanen C; van Essen GJ; Minke J; Daly JM; Yates PJ
    Vet Microbiol; 2003 Jun; 93(4):291-306. PubMed ID: 12713892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia.
    Burnell FJ; Holmes MA; Roiko AH; Lowe JB; Heil GL; White SK; Gray GC
    J Clin Virol; 2014 Feb; 59(2):100-3. PubMed ID: 24360918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel equine influenza virus live-attenuated vaccine.
    Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
    Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the endpoint of an outbreak of equine influenza in a large population of racing Thoroughbreds.
    Ryan D
    Aust Vet J; 2011 Jul; 89 Suppl 1():25-7. PubMed ID: 21711278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.